Alexandr Kristian

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Liver X receptors induce antiproliferative effects in basal-like breast cancer.

Liver X receptors induce antiproliferative effects in basal-like breast cancer.

Journal: Molecular oncology

Published: June 28, 2022

Ultra-early changes in vascular parameters from dynamic contrast enhanced MRI of breast cancer xenografts following systemic therapy with doxorubicin and liver X receptor agonist.

Ultra-early changes in vascular parameters from dynamic contrast enhanced MRI of breast cancer xenografts following systemic therapy with doxorubicin and liver X receptor agonist.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: June 17, 2019

Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts.

Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts.

Journal: Molecular imaging and biology

Published: August 20, 2016

STAMP2 is required for human adipose-derived stem cell differentiation and adipocyte-facilitated prostate cancer growth in vivo.

STAMP2 is required for human adipose-derived stem cell differentiation and adipocyte-facilitated prostate cancer growth in vivo.

Journal: Oncotarget

Published: May 24, 2016

Variability of dynamic 18F-FDG-PET data in breast cancer xenografts.

Variability of dynamic 18F-FDG-PET data in breast cancer xenografts.

Journal: Acta oncologica (Stockholm, Sweden)

Published: July 29, 2015

STAMP2 increases oxidative stress and is critical for prostate cancer.

STAMP2 increases oxidative stress and is critical for prostate cancer.

Journal: EMBO molecular medicine

Published: February 15, 2015

Positron emission tomography and pharmacokinetics of 2-[18F]-fluoroethyl choline for metabolic studies in breast cancer xenografts.

Positron emission tomography and pharmacokinetics of 2-[18F]-fluoroethyl choline for metabolic studies in breast cancer xenografts.

Journal: Acta oncologica (Stockholm, Sweden)

Published: July 15, 2014

Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.

Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.

Journal: PloS one

Published: July 01, 2014

Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model.

Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model.

Journal: Gene therapy

Published: June 28, 2014

Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations.

Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 07, 2013

In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts.

In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts.

Journal: Journal of magnetic resonance imaging : JMRI

Published: October 01, 2013

Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts.

Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts.

Journal: Acta oncologica (Stockholm, Sweden)

Published: August 30, 2013

Showing 1-12 of 20

Last Updated: 09/26/2026